When preeclampsia strikes twice: A mother’s harrowing experience with preeclampsia recurrence

As a mother who’d already experienced preeclampsia during her first pregnancy, Crystal Dock went into her second pregnancy feeling somewhat cautious. Preeclampsia is a high blood pressure disorder that can restrict blood supply to the developing baby and increase the risk of pregnancy complications. Early detection is crucial to help avoid these complications.

Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference

BURLINGTON, N.C. , May 28, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the 44th Annual William Blair Growth Stock Conference on

More women are being diagnosed with preeclampsia. New testing from Labcorp could save lives with earlier detection

With preeclampsia on the rise and a lack of robust preeclampsia screening guidelines and options, Labcorp's new preeclampsia tests can support early detection.

Leading the way in new study options rooted in the 3Rs with genetic toxicology and in vitro alternatives

Cary Johnson

Cary Johnson is a board-certified pathologist with the certifications in Anatomic and Clinical Pathology. Before joining Dianon Pathology, he served as a pathologist in several hospitals and private lab settings the last of which was in the University of California system of hospitals with the assignment of full Professor of Pathology.

Leveraging global laboratory scale to deliver critical patient test results on time

Physicians attending to critically ill cancer patients awaited test results from Labcorp's Los Angeles Center of Excellence for Advanced Anatomic Pathology and Histology. These results would determine patients’ eligibility for enrollment in clinical trials that could positively impact the progression of their disease. Unfortunately, the Labcorp laboratory team encountered an unexpected issue with the performance of certain lots of testing reagents.

Labcorp Announces Retirement of Dr. R. Sanders Williams and Mr. Jean-Luc Bélingard from Its Board of Directors

BURLINGTON, N.C., May 16, 2024 — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that Dr. R. Sanders Williams and Mr. Jean-Luc Bélingard have retired from its board of directors at the conclusion of their current terms on May 14, 2024. Dr.

Leading through a lab management transition: Fireside chat with Lugard Igharo, regional lab director and former Ascension employee

Lu Igharo, regional lab director, Labcorp (formerly Ascension), and Bryan Vaughn, senior vice president of health systems, Labcorp, discuss the Ascension and Labcorp lab management transition process, including the Ascension lab team’s initial reaction to the partnership announcement and how the sentiment has grown to be overwhelmingly positive in the time since. 

Automation advancements at our central laboratory

See how state-of-the-art technologies at our Indianapolis central lab enhance sample processing to better support of your mission and bring new therapeutics to patients.